found that both interleukin-2 (IL-2) and interleukin-15 (IL-15) can be used as effective costimulatory signals to enhance breast cancer CD8+ T cell proliferation and interferon-γ (IFN -γ) Production. Here, IL2 is linked to breast carcinoma.